STRATEC Biomedical AG
Open
17.48 3.43
Overview
Share price change
24h
Min
16.68
Max
17.74
Income | 2.6M -1.7M |
|---|---|
Sales | -22M 53M |
P/E Sector Avg | 14.63 30.136 |
EPS | -0.357 |
Dividend yield | 3.3 |
Profit margin | -3.206 |
Employees | 1,395 |
EBITDA | -6.7M 4.1M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +55.9% upside |
Dividend yield Sector Avg | 3.30% 3.27% |
|---|---|
Next Earnings | 14 sie 2026 |
Market Cap | 6.8M 221M |
|---|---|
Previous open | 14.05 |
Previous close | 17.48 |
STRATEC Biomedical AG Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About STRATEC Biomedical AG
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
